SCHEMBL19257810

SCHEMBL19257810

CCCCCCCCC(=O)OC[C@H](O)CC[C@H](O)COC(=O)CCCCCCCC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.77
KDM4E B2RXH2 1/20 0.77
DUSP3 P51452 1/20 0.77
MEN1 O00255 1/20 0.77
KMT2A Q03164 1/20 0.77
MAPT P10636 1/20 0.71
ENPP2 Q13822 4/20 0.67
LPAR1 Q92633 3/20 0.67
LPAR6 P43657 1/20 0.67
LPAR4 Q99677 1/20 0.67
LPAR5 Q9H1C0 1/20 0.67
LPAR2 Q9HBW0 1/20 0.67
LPAR3 Q9UBY5 1/20 0.67
DGKA P23743 2/20 0.65
ALDH1A1 P00352 1/20 0.64
TRPV1 Q8NER1 1/20 0.61
CYP3A4 P08684 1/20 0.59
TSHR P16473 1/20 0.59
ATM Q13315 1/20 0.59
TDP1 Q9NUW8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291702 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL27735372 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL15167005 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL9730359 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL21425791 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL28901086 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL11189015 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL11297688 0.95 LMNA (0.75) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL19257816 0.93 LMNA (0.84) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL19257803 0.93 LMNA (0.84) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233337-A1 NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME ARCHER DANIELS MIDLAND CO (IL) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233337-A1 NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME PNLIP, FFAR4, SPTLC2 LMNA 2175/4885KDM4E 2921/4885DUSP3 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.